Venoarterial extracorporeal membrane oxygenation in immunocompromised patients with cardiogenic shock: a cohort study and propensity-weighted analysis.
Quentin MoyonFélicien TribouletJean ReuterGuillaume LebretonAmandine DorgetMarylou ParaJuliette ChommelouxJules SternMarc Pineton de ChambrunGuillaume HékimianCharles-Edouard LuytAlain CombesRomain SonnevilleMatthieu SchmidtPublished in: Intensive care medicine (2024)
Immunocompromised patients undergoing VA-ECMO treatment face an unfavorable prognosis, with higher 90-day mortality compared to non-immunocompromised patients. This underscores the necessity for thorough evaluation and careful selection of ECMO candidates within this frail population.
Keyphrases
- extracorporeal membrane oxygenation
- respiratory failure
- acute respiratory distress syndrome
- patients undergoing
- end stage renal disease
- ejection fraction
- mechanical ventilation
- chronic kidney disease
- magnetic resonance
- peritoneal dialysis
- prognostic factors
- cardiovascular events
- contrast enhanced
- clinical evaluation